-->
Login
Get Started
Healthcare
Biotechnology & Medical Research
Oxford BioMedica
All Posts
The most recent posts from across the site.
Votes
Title
Posted by
Comments
Unread
0
Market Musings 131225: Santa Rally incoming?
Learning to Invest
Edmund Shing
just secs ago
0
0
40
The Week Ahead (15-19 Dec): BoE interest rate decision + NKE, CURY & SMWH
Stock Picks
Roland Head
Fri 10:10am
3
3
60
The Week Ahead (8 – 12 Dec): US Interest Rates, Costco, Adobe, Moonpig, RWS
Stock Picks
Mark Simpson
4th Dec
16
16
70
What should I do with my Magnum Ice Cream shares?
Stock Picks
Roland Head
4th Dec
18
18
74
How to sleuth for a data-driven edge in gaming companies
Momentum Investing
Edward Croft
13th Nov
5
5
73
My highlights from Mello 2025
Stock Picks
Roland Head
26th Nov
4
4
163
Webinar Discussion - How Phil Hoffer achieved 17% annualised for 13 years
StockRanks
Edward Croft
24th Oct
203
203
58
The Week Ahead (1st - 5th December): The small but surprising market impact of the Budget
Stock Picks
Graham Neary
28th Nov
29
29
115
Daily Stock Market Report (Thur 24 April 2025) - SOM, REL, SUPR, RWS, BRCK, JUP, GBG, DIAL, PEN, CKT, VNET, EAH, SFR, SAG, ASC, XPP
Stock Picks
Graham Neary
24th Apr
48
48
93
Market Musings 301125: Ideas for H1 2026
Learning to Invest
Edmund Shing
30th Nov
9
9
113
Ten small-cap value and growth ideas for 2025: H1 Review
Stock Picks
Graham Neary
9th Jul
9
9
75
The Goldilocks Portfolio: How many stocks is ‘Just Right’?
Folio Management
Alex Naamani
19th Nov
46
46
98
Market Musings 151125: The Energy Boom is here!
Learning to Invest
Edmund Shing
15th Nov
14
14
57
The Week Ahead (24-28 Nov): it’s all about the Budget (& Nvidia!) + AO., PETS, CBOX
Stock Picks
Roland Head
21st Nov
5
5
122
The unusual opportunity in PE Investment Trusts
Stock Picks
Graham Neary
18th Jun
33
33
79
Market Musings 221125: H1 2026 Outlook
Learning to Invest
Edmund Shing
22nd Nov
2
2
130
NAPS Portfolio gains 22% in 6 months - is this a straight up year?
StockRanks
Edward Croft
30th Jun
62
62
87
What's the right strategy for a newbie investor?
Value Investing
Mark Simpson
13th Aug
31
31
188
The Setup – three simple rules that captured the 36% drift in H1 2025
Technical Analysis
Edward Croft
17th Jun
178
178
66
The Week Ahead (17 – 21 Nov): Mello, US Housing, UK Inflation, NVDA, US Value Retail, LIO, CML, MTO
Stock Picks
Mark Simpson
14th Nov
10
10
112
How to screen for high-return bowls
Stock Picks
Mark Simpson
28th Oct
38
38
57
Should investors back 4Imprint’s next chapter?
Stock Picks
Roland Head
13th Nov
4
4
88
All that glitters is gold (producers) – Part 2
Stock Picks
Mark Simpson
15th Oct
21
21
69
After an eventful two years, has my quality screen beaten the market?
Stock Screening
Roland Head
21st Jul
11
11
68
The Week Ahead (10-14 Nov): Budget uncertainty, VOD, BME, QQ
Stock Picks
Roland Head
6th Nov
12
12
80
Beating the FTSE 100 with Dividend Dogs: portfolio update
Stock Picks
Roland Head
23rd Oct
15
15
67
Bowled over or getting the hump?
Stock Screening
Mark Simpson
3rd Nov
6
6
120
The Hump and the Bowl - understanding the patterns of Momentum
Momentum Investing
Edward Croft
22nd Oct
17
17
71
The Week Ahead (3rd - 7th November): Interest Rate & Budget Countdown
Stock Picks
Graham Neary
31st Oct
32
32
102
Market Musings 251025: Stock bull market in full flow
Learning to Invest
Edmund Shing
25th Oct
3
3
69
PPHE: 50p for a Pound
Stock Picks
Graham Neary
24th Oct
14
14
197
Small Cap Value Report (Tue 25 June 2024) - VTU, IGR, PRES. Briefs: FCH, SAE, ORCH, G4M, SAGA, CDGP, ANP, WYN, HUD
Stock Picks
Paul Scott
25th Jun '24
73
73
57
The Week Ahead (27 – 31 Oct): Interest Rates, UK House Prices, US Big Tech, Global Payment Networks, NXT, RWS
Stock Picks
Mark Simpson
24th Oct
14
14
79
The Week Ahead (20 – 24 Oct): Gold, Inflation, TSLA, US Defence, SCT, GATC
Stock Picks
Mark Simpson
17th Oct
9
9
62
How Warren Buffett achieved extraordinary results without being extraordinary
Value Investing
Alex Naamani
20th Oct
7
7
Newer
1
2
3
4
5
6
7
8
Older
Discover the metrics influencing Oxford BioMedica's share price
Take a free trial
© Stockopedia 2025, Refinitiv, Share Data Services.
Facebook
Twitter
Youtube
Instagram
RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our
Terms of Use
,
Privacy
and
Disclaimer
policies.
Discover the metrics influencing Oxford BioMedica's share price
Take a free trial